Pseudoephedrine accumulation in renal failure (case report)

Neuropsychiatric complications, such as metabolic encephalopathy, are common occurrences in end-stage renal disease (ESRD) patients. Frequently, metabolic encephalopathy develops in relationship to the multiple pharmacologic therapies routinely employed in this population. Such polypharmacy often le...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of the medical sciences 1989-10, Vol.298 (4), p.261-263
Main Authors: SICA, D. A, COMSTOCK, T. J
Format: Article
Language:English
Subjects:
Biological and medical sciences
Drug intoxications. Doping
Ephedrine - adverse effects
Ephedrine - blood
Humans
Kidney Failure, Chronic - metabolism
Kidney Failure, Chronic - therapy
Male
Medical sciences
Middle Aged
Myoclonus - chemically induced
Pharmacology. Drug treatments
Renal Dialysis
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 263
container_issue 4
container_start_page 261
container_title The American journal of the medical sciences
container_volume 298
creator SICA, D. A
COMSTOCK, T. J
description Neuropsychiatric complications, such as metabolic encephalopathy, are common occurrences in end-stage renal disease (ESRD) patients. Frequently, metabolic encephalopathy develops in relationship to the multiple pharmacologic therapies routinely employed in this population. Such polypharmacy often leads to adverse drug reactions, drug-drug interactions, or dosage error. In this regard, over-the-counter (OTC) medications are commonly perceived as being "somewhat benign" when, in fact, their potential for adverse effect may be significant. The authors describe the course of a 64-year-old hemodialysis patient who became intoxicated on conventional doses of pseudoephedrine only to regain neurologic integrity upon discontinuation of the medication.
doi_str_mv 10.1097/00000441-198910000-00010
format article
fullrecord <record><control><sourceid>pubmed_pasca</sourceid><recordid>TN_cdi_pubmed_primary_2801760</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2801760</sourcerecordid><originalsourceid>FETCH-LOGICAL-p137t-c0f5f2b82c80827e4f1d243e11b4ec8f4ba1320e0a37edfeb700cf10143f74683</originalsourceid><addsrcrecordid>eNo9j81LxDAQxYMoa139E4ReBD1EZ5K0SfAki1-woAc9L2k6wUq_SNqD_71dXBx4DO_3HgPDWI5wi2D1HexHKeRojcW94YsQjliGhTRcWAvHLFuY4LYU9pSdpfS9NIRBuWIrYQB1CRm7f0801wONX1THpqfceT93c-umZujzps8j9a7Ng2vaOVJ-7V2ihY1DnG7O2UlwbaKLw16zz6fHj80L3749v24etnxEqSfuIRRBVEZ4A0ZoUgFroSQhVoq8CapyKAUQOKmpDlRpAB8QUMmgVWnkml3-3R3nqqN6N8amc_Fnd3hiya8OuUvetSG63jfpv4ZWmMIWpfwFSldW7Q</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Pseudoephedrine accumulation in renal failure (case report)</title><source>ScienceDirect Additional Titles</source><creator>SICA, D. A ; COMSTOCK, T. J</creator><creatorcontrib>SICA, D. A ; COMSTOCK, T. J</creatorcontrib><description>Neuropsychiatric complications, such as metabolic encephalopathy, are common occurrences in end-stage renal disease (ESRD) patients. Frequently, metabolic encephalopathy develops in relationship to the multiple pharmacologic therapies routinely employed in this population. Such polypharmacy often leads to adverse drug reactions, drug-drug interactions, or dosage error. In this regard, over-the-counter (OTC) medications are commonly perceived as being "somewhat benign" when, in fact, their potential for adverse effect may be significant. The authors describe the course of a 64-year-old hemodialysis patient who became intoxicated on conventional doses of pseudoephedrine only to regain neurologic integrity upon discontinuation of the medication.</description><identifier>ISSN: 0002-9629</identifier><identifier>EISSN: 1538-2990</identifier><identifier>DOI: 10.1097/00000441-198910000-00010</identifier><identifier>PMID: 2801760</identifier><identifier>CODEN: AJMSA9</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott</publisher><subject>Biological and medical sciences ; Drug intoxications. Doping ; Ephedrine - adverse effects ; Ephedrine - blood ; Humans ; Kidney Failure, Chronic - metabolism ; Kidney Failure, Chronic - therapy ; Male ; Medical sciences ; Middle Aged ; Myoclonus - chemically induced ; Pharmacology. Drug treatments ; Renal Dialysis</subject><ispartof>The American journal of the medical sciences, 1989-10, Vol.298 (4), p.261-263</ispartof><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19285956$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2801760$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SICA, D. A</creatorcontrib><creatorcontrib>COMSTOCK, T. J</creatorcontrib><title>Pseudoephedrine accumulation in renal failure (case report)</title><title>The American journal of the medical sciences</title><addtitle>Am J Med Sci</addtitle><description>Neuropsychiatric complications, such as metabolic encephalopathy, are common occurrences in end-stage renal disease (ESRD) patients. Frequently, metabolic encephalopathy develops in relationship to the multiple pharmacologic therapies routinely employed in this population. Such polypharmacy often leads to adverse drug reactions, drug-drug interactions, or dosage error. In this regard, over-the-counter (OTC) medications are commonly perceived as being "somewhat benign" when, in fact, their potential for adverse effect may be significant. The authors describe the course of a 64-year-old hemodialysis patient who became intoxicated on conventional doses of pseudoephedrine only to regain neurologic integrity upon discontinuation of the medication.</description><subject>Biological and medical sciences</subject><subject>Drug intoxications. Doping</subject><subject>Ephedrine - adverse effects</subject><subject>Ephedrine - blood</subject><subject>Humans</subject><subject>Kidney Failure, Chronic - metabolism</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myoclonus - chemically induced</subject><subject>Pharmacology. Drug treatments</subject><subject>Renal Dialysis</subject><issn>0002-9629</issn><issn>1538-2990</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><recordid>eNo9j81LxDAQxYMoa139E4ReBD1EZ5K0SfAki1-woAc9L2k6wUq_SNqD_71dXBx4DO_3HgPDWI5wi2D1HexHKeRojcW94YsQjliGhTRcWAvHLFuY4LYU9pSdpfS9NIRBuWIrYQB1CRm7f0801wONX1THpqfceT93c-umZujzps8j9a7Ng2vaOVJ-7V2ihY1DnG7O2UlwbaKLw16zz6fHj80L3749v24etnxEqSfuIRRBVEZ4A0ZoUgFroSQhVoq8CapyKAUQOKmpDlRpAB8QUMmgVWnkml3-3R3nqqN6N8amc_Fnd3hiya8OuUvetSG63jfpv4ZWmMIWpfwFSldW7Q</recordid><startdate>19891001</startdate><enddate>19891001</enddate><creator>SICA, D. A</creator><creator>COMSTOCK, T. J</creator><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>19891001</creationdate><title>Pseudoephedrine accumulation in renal failure (case report)</title><author>SICA, D. A ; COMSTOCK, T. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p137t-c0f5f2b82c80827e4f1d243e11b4ec8f4ba1320e0a37edfeb700cf10143f74683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Biological and medical sciences</topic><topic>Drug intoxications. Doping</topic><topic>Ephedrine - adverse effects</topic><topic>Ephedrine - blood</topic><topic>Humans</topic><topic>Kidney Failure, Chronic - metabolism</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myoclonus - chemically induced</topic><topic>Pharmacology. Drug treatments</topic><topic>Renal Dialysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SICA, D. A</creatorcontrib><creatorcontrib>COMSTOCK, T. J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>The American journal of the medical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SICA, D. A</au><au>COMSTOCK, T. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pseudoephedrine accumulation in renal failure (case report)</atitle><jtitle>The American journal of the medical sciences</jtitle><addtitle>Am J Med Sci</addtitle><date>1989-10-01</date><risdate>1989</risdate><volume>298</volume><issue>4</issue><spage>261</spage><epage>263</epage><pages>261-263</pages><issn>0002-9629</issn><eissn>1538-2990</eissn><coden>AJMSA9</coden><abstract>Neuropsychiatric complications, such as metabolic encephalopathy, are common occurrences in end-stage renal disease (ESRD) patients. Frequently, metabolic encephalopathy develops in relationship to the multiple pharmacologic therapies routinely employed in this population. Such polypharmacy often leads to adverse drug reactions, drug-drug interactions, or dosage error. In this regard, over-the-counter (OTC) medications are commonly perceived as being "somewhat benign" when, in fact, their potential for adverse effect may be significant. The authors describe the course of a 64-year-old hemodialysis patient who became intoxicated on conventional doses of pseudoephedrine only to regain neurologic integrity upon discontinuation of the medication.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott</pub><pmid>2801760</pmid><doi>10.1097/00000441-198910000-00010</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9629
ispartof The American journal of the medical sciences, 1989-10, Vol.298 (4), p.261-263
issn 0002-9629
1538-2990
language eng
recordid cdi_pubmed_primary_2801760
source ScienceDirect Additional Titles
subjects Biological and medical sciences
Drug intoxications. Doping
Ephedrine - adverse effects
Ephedrine - blood
Humans
Kidney Failure, Chronic - metabolism
Kidney Failure, Chronic - therapy
Male
Medical sciences
Middle Aged
Myoclonus - chemically induced
Pharmacology. Drug treatments
Renal Dialysis
title Pseudoephedrine accumulation in renal failure (case report)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T10%3A36%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pseudoephedrine%20accumulation%20in%20renal%20failure%20(case%20report)&rft.jtitle=The%20American%20journal%20of%20the%20medical%20sciences&rft.au=SICA,%20D.%20A&rft.date=1989-10-01&rft.volume=298&rft.issue=4&rft.spage=261&rft.epage=263&rft.pages=261-263&rft.issn=0002-9629&rft.eissn=1538-2990&rft.coden=AJMSA9&rft_id=info:doi/10.1097/00000441-198910000-00010&rft_dat=%3Cpubmed_pasca%3E2801760%3C/pubmed_pasca%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p137t-c0f5f2b82c80827e4f1d243e11b4ec8f4ba1320e0a37edfeb700cf10143f74683%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/2801760&rfr_iscdi=true